# Dianthus Therapeutics, Inc.: Form DEF 14A, filed Apr 21, 2021

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: DEF 14A
- Filed: 2021-04-21
- Accepted by EDGAR: Apr 21, 2021, 08:00 ET
- Period: 2021-06-01
- Accession: 0001193125-21-123656
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm

Filed Apr 21, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-123656. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
